NeuPath Health Correlations
| NPTH Stock | CAD 0.50 0.04 8.70% |
The current 90-days correlation between NeuPath Health and Royal Road Minerals is 0.07 (i.e., Very good diversification).When its correlation with a broad index is high, most of the stock's return is explained by market movement.
Market Correlation Snapshot: NeuPath Health
Very good diversification
Across the chosen horizon, NeuPath Health and Dow Jones show a correlation of 0.08 and fall into the Very good diversification bucket. The overlap area shows the portion of risk that can be diversified away by holding both instruments together.
NeuPath |
Co-movement patterns for NeuPath Health are summarized using correlation data. This view includes regulatory context as part of the dataset.
Moving against NeuPath Stock
| 0.74 | PPL | Pembina Pipeline Corp | PairCorr |
| 0.72 | CXI | Currency Exchange | PairCorr |
| 0.68 | WMT | Walmart CDR | PairCorr |
| 0.65 | NPS | Canadian Large Cap Split | PairCorr |
| 0.59 | NTR | Nutrien | PairCorr |
| 0.46 | SHL | Homeland Nickel Earnings Call This Week | PairCorr |
| 0.45 | ACL | ACL Construction | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
Evaluating NeuPath Stock requires separating price momentum from underlying operating strength versus competitors. Risk-adjusted metrics help compare NeuPath Health's efficiency and downside exposure against peers on a like-for-like basis. These indicators are quantitative in nature and help investors evaluate volatility and risk-adjusted expected returns across different positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DCM | 1.90 | -0.06 | 0.00 | 0.32 | 0.00 | 5.04 | 11.81 | |||
| ELBM | 3.57 | -0.42 | 0.00 | -0.25 | 0.00 | 7.46 | 24.66 | |||
| NEXG | 3.63 | -0.16 | 0.00 | -0.17 | 0.00 | 6.21 | 20.93 | |||
| RYR | 3.14 | 0.06 | 0.00 | -0.03 | 0.00 | 9.09 | 22.02 | |||
| AGF-B | 1.33 | 0.35 | 0.22 | 0.41 | 1.32 | 3.68 | 10.56 | |||
| CS | 3.02 | -0.18 | 0.00 | -0.15 | 0.00 | 5.61 | 19.13 | |||
| DBM | 1.27 | 0.17 | 0.10 | 0.08 | 1.46 | 2.97 | 8.80 |
Be your own money manager
Serious investors usually evaluate NeuPath Health in portfolio context because a good security can still be a weak addition if it increases concentration or unnecessary volatility. A stronger allocation process asks what the position adds to the portfolio, not just what it might do on its own.
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
NeuPath Health Corporate Management
Governance review matters for NeuPath Health because boards and executives shape oversight, strategic discipline, and how shareholder interests are represented. A disciplined governance review can reveal strengths or weaknesses that may not be obvious in financial ratios alone.
| Joseph MBA | Interim Director | Profile | |
| Sandee Cruz | Chief Officer | Profile | |
| Geeta Vadgama | Vice Operations | Profile | |
| Bjorn Thies | Vice Culture | Profile |